Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
New 3-Times-Per-Week Regimen For Teva’s Copaxone Safe, Effective & Increases Patient Compliance #ECTRIMS2015
Increasing Physical Activity and Participation in People with Multiple Sclerosis: A Review.
Neuromuscular Determinants For Walking Performance In Individuals With Multiple Sclerosis: 2570 Board #93 June 3, 9: 30 AM - 11: 00 AM.
YAP and TAZ control peripheral myelination and the expression of laminin receptors in Schwann cells.
Uncovering the Role of the Methylome in Dementia and Neurodegeneration.
Retinal imaging and axonal degeneration in later onset multiple sclerosis.
Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis.
The Gut Microbiota in Immune-Mediated Inflammatory Diseases.
Inhibition of Vascular Endothelial Growth Factor Receptor 2 Exacerbates Loss of Lower Motor Neurons and Axons during Experimental Autoimmune Encephalomyelitis.
Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree.
Low serum uric acid levels in patients with multiple sclerosis and neuromyelitis optica: An updated meta-analysis.
Is size an essential criterion to define tumefactive plaque? MR features and clinical correlation in multiple sclerosis.
Peripheral neuropathy in patients with myotonic dystrophy type 2.
Neuromuscular Diseases.
Correlation between antibodies to bisphenol A, its target enzyme protein disulfide isomerase and antibodies to neuron-specific antigens.
Complex coacervation for the development of composite edible films based on LM pectin and sodium caseinate.
Molecular characterization of biotic and abiotic stress-responsive MAP kinase genes, IbMPK3 and IbMPK6, in sweetpotato.
[Anti-NMDA Receptor Antibody-Related Encephalitis].
Transgenerational attenuation of opioid self-administration as a consequence of adolescent morphine exposure.
Imaging of Central Nervous System Demyelinating Disorders.
A case of chronic inflammatory demyelinating polyradiculoneuropathy after treatment with pegylated interferon α-2a in a patient with chronic hepatitis B virus infection.
Suspected Acoustic Neuroma Demyelinating Lesions.
Self-induced drug intoxication in baclofen: of the calm hypotonic coma in the status epilepticus.
Field inhomogeneity correction for gradient echo myelin water fraction imaging.
Distinct pattern of lesion distribution in multiple sclerosis is associated with different circulating T-helper and helper-like innate lymphoid cell subsets.
Pages
« first
‹ previous
…
795
796
797
798
799
800
801
802
803
…
next ›
last »